fbpx
Select Page
CDC Recommends 2 COVID Vaccines for Very Young Children

CDC Recommends 2 COVID Vaccines for Very Young Children

NEW YORK TIMES June 18, 2022- The Centers for Disease Control and Prevention on Saturday recommended Covid vaccines for children as young as 6 months, who were among the last Americans to qualify for the shots. Parents should be able to start getting young children...
COVID-19 Therapies, Treatment & Prevention

COVID-19 Therapies, Treatment & Prevention

It is hard to imagine that it has been two years since our lives changed completely due to the onset of SARS-CoV-2, COVID-19. The pandemic has halted our lives for over two years. At different times, we have witnessed surges in all parts of the world and in all cities...
Updated COVID Guidance & Recommendations for Alphas

Updated COVID Guidance & Recommendations for Alphas

April 8, 2022- Important COVID-19 Omicron Variant Update At the beginning of 2022 an Omicron variant caused a surge in cases. Patients infected with this variant development mild illness. Most recently, a second variant has taken over which is another form of Omicron....
What to Know About the KF94 Mask

What to Know About the KF94 Mask

The following information was published in the New York Times. To access the full article, please click here.   Even as mask mandates begin to lift across the country, many people still need high-quality masks for air travel, shopping and visiting the doctor. One of...
COVID-19 Omicron Update

COVID-19 Omicron Update

Missed the COVID-19 Omicron Update Webinar? Watch the webinar now on-demand to hear the answers of frequently asked questions relating to Omicron, vaccines, and more! Click here to view the recording. To view the most recent frequently asked questions, click...
FDA Takes Key Action by Approving Second COVID-19 Vaccine

FDA Takes Key Action by Approving Second COVID-19 Vaccine

Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older. Key...